FindTrial
Sign In

Cost-effectiveness analysis of treatment of rheumatoid arthritis in Beijing specialist "graded diagnosis and treatment"

Cost-effectiveness analysis of treatment of rheumatoid arthritis in Beijing specialist "graded diagnosis and treatment"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057562
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

None listed

Sponsors

Fuxing Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of rheumatoid arthritis is clear; 2. Resident in Beijing area; 3. Age: 18 to 80 years old; 4. Continuous regular treatment for 1 year; 5. Provide specialist fee records within 1 year of observation period.

Exclusion criteria

Exclusion criteria: 1. Baseline exclusion criteria: cognitive impairment. 2. End point exclusion criteria: (1) The number of specialist visits during the observation period was less than 3; (2) The number of visits outside Beijing is more than 20% in the whole year; (3) The number of complete medical information is less than 50%; (4) Participate in clinical trials of treatment methods during the observation period; (5) Enjoy medical commercial gifts during the observation period.

Design outcomes

Primary

MeasureTime frame
Sociodemographic characteristics;DAS28-CRP/ESR;Rheumatic Disease Comorbidity Index, RDCI;Health Related Quality of Life;Visit cost;Visit time cost;Visit distance cost;—

Countries

China

Contacts

Public ContactLi Mingwei

Fuxing Hospital, Capital Medical University

vivali2000@126.com+86 13146632862

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026